US 9498529
Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor
granted A61KA61K2039/505A61K39/145
Quick answer
US patent 9498529 (Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/505, A61K39/145, A61K39/3955, A61K39/42